Centre for Policy on Ageing
 

 

Geriatric psychopharmacology
Author(s)J Craig Nelson
PublisherMarcel Dekker, New York, 1998
Pages469 pp (Medical psychiatry, 9)
SourceMarcel Dekker, Inc., Cimarron Road, PO Box 5005, Monticello, NY 12701-5185, USA.
KeywordsDrugs ; Psychiatric treatment ; Mental disorder ; Depression ; Psychoses ; Anxiety ; Dementia ; Research.
AnnotationChapters on neurochemistry in ageing, pharmacokinetics, and drug interactions provide a foundation for subsequent chapters which focus on specific disorders. A section on depression - including a research review of maintenance therapies - deals with the treatment of major depression, psychotic depression, and major depressions during bereavement. Part 3 concerns the treatment of depression with associated conditions: cardiac disease, post-stroke psychiatric disorders, cancer, Parkinson's disease, dementia, and medical illness. Little has been written previously regarding treatment of geriatric patients with manic syndromes or bipolar disorders: the use of lithium, its toxicity, and the use of anti-convulsants are discussed. Sections 5 and 6 deal with late-life psychosis, and anxiety disorders (use of sedative hypnotics), including the treatment of generalised anxiety disorder, panic disorder, and obsessive-compulsive disorder. The final section, on dementia, discusses use of cognitive enhancers, neuroleptics for behavioural complications, and non-neuroleptic treatment of complications of dementia. (RH).
Accession NumberCPA-980707209 B
ClassmarkLLD: LP: E: ENR: EL: ENP: EA: 3A

Data © Centre for Policy on Ageing

...from the Ageinfo database published by Centre for Policy on Ageing.
 

CPA home >> Ageinfo Database >> Queries to: webmaster@cpa.org.uk